China Isotope & Radiation Corporation (FRA:5IR)

Market Cap	589.56M -5.8%
Revenue (ttm)	875.23M -5.1%
Net Income	39.87M -19.5%
EPS	0.12 -19.5%
Shares Out	n/a
PE Ratio	14.79
Forward PE	n/a
Dividend	0.04 (2.24%)
Ex-Dividend Date	Jun 23, 2026

Volume	n/a
Open	1.670
Previous Close	1.720
Day's Range	1.670 - 1.750
52-Week Range	1.650 - 2.480
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About China Isotope & Radiation

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of nuclides, diagnostic, and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. The company operates through five segments: Nuclear Medicines; Radioactive Source Products; Irradiation; Nuclear Medical Equipment and Related Services; and Other Businesses. The Nuclear Medicines segment engages in research, development, manufacture, and sale of imaging diagnostic and therapeutic radiop...

• Industry: Industrial Inorganic Chemicals
• Founded: 1983
• Employees: 3,578
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5IR

Financial Performance

In 2025, China Isotope & Radiation's revenue was 7.19 billion, a decrease of -5.11% compared to the previous year's 7.57 billion. Earnings were 327.43 million, a decrease of -19.48%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error